Lisata Therapeutics Inc (LSTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Sales | 11,565 | 84 | 232 | 46 | 35 |
| Cost of Goods | 9,706 | 32 | 25 | 22 | 25 |
| Gross Profit | 1,859 | 52 | 207 | 23 | 11 |
| Operating Expenses | 28,434 | 9,317 | 10,671 | 4,737 | 1,636 |
| Operating Income | -25,869 | -9,234 | -10,439 | -4,691 | -1,601 |
| Interest Expense | 23 | 12 | 22 | 1,381 | 144 |
| Other Income | -16 | 3 | 15 | 20 | 0 |
| Pre-tax Income | -25,908 | -9,242 | -10,446 | -6,051 | -1,745 |
| Income Tax | 42 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -25,950 | -9,242 | -10,446 | -6,051 | -1,745 |
| Minority Interests | 221 | N/A | N/A | N/A | N/A |
| Net Income | $-26,171 | $-9,242 | $-10,446 | $-6,051 | $-1,745 |
| EPS Basic Total Ops | -3,658.17 | -2,293.85 | -4,767.62 | -6,641.68 | -5,262.37 |
| EPS Basic Continuous Ops | -2,988.22 | -2,287.67 | -4,768.52 | -6,646.44 | -5,256.07 |
| EPS Diluted Total Ops | -3,658.17 | -2,293.85 | -4,767.62 | -6,641.68 | -5,262.37 |
| EPS Diluted Continuous Ops | -2,988.22 | -2,287.67 | -4,768.52 | -6,646.44 | -5,256.07 |
| EBITDA(a) | $-25,149 | $-9,118 | $-10,385 | $-4,664 | $-1,599 |